New Blood Biomarker for Alzheimer's Disease via ELISA
Alzheimer's Disease (AD) is the main neurodegenerative disease worldwide affecting more than 15 Mill. people. An easy AD blood diagnostic method does not exist, as well as an early predictive AD biomarker. Scientists of the University of Göttingen identified a novel Blood Biomarker for the Diagnosis of Alzheimer's Disease (AD) which correlates with the cognitive status of individuals at risk to develop AD including mild cognitive impairment (MCI) patients, as well as a corresponding ELISA methodology.
Further Information: PDF
MBM ScienceBridge GmbH
Phone: (0551) 30724-152
Contact
Dr. Jens-Peter Horst
Media Contact
All latest news from the category: Technology Offerings
Newest articles
A universal framework for spatial biology
SpatialData is a freely accessible tool to unify and integrate data from different omics technologies accounting for spatial information, which can provide holistic insights into health and disease. Biological processes…
How complex biological processes arise
A $20 million grant from the U.S. National Science Foundation (NSF) will support the establishment and operation of the National Synthesis Center for Emergence in the Molecular and Cellular Sciences (NCEMS) at…
Airborne single-photon lidar system achieves high-resolution 3D imaging
Compact, low-power system opens doors for photon-efficient drone and satellite-based environmental monitoring and mapping. Researchers have developed a compact and lightweight single-photon airborne lidar system that can acquire high-resolution 3D…
